Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic... Key PointsQuestionAre there clinical benefits associated with real-time continuous glucose monitoring (CGM) among patients with insulin-treated diabetes? FindingsIn this retrospective cohort study in a usual care setting that included 5673 patients with type 1 diabetes and 36 080 patients with type 2 diabetes, use of real-time CGM compared with nonuse was associated with significantly lower hemoglobin A1c (difference, −0.40%) and lower rates of emergency department visits or hospitalizations for hypoglycemia (difference, −2.73%) but no significant difference for rates of emergency department visits or hospitalizations for hyperglycemia or for other reasons. MeaningAmong patients selected by physicians for real-time continuous glucose monitoring use was associated with better glycemic control and lower rates of hypoglycemia. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

Loading next page...
 
/lp/american-medical-association/association-of-real-time-continuous-glucose-monitoring-with-glycemic-Lm3100lRNE
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2021.6530
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionAre there clinical benefits associated with real-time continuous glucose monitoring (CGM) among patients with insulin-treated diabetes? FindingsIn this retrospective cohort study in a usual care setting that included 5673 patients with type 1 diabetes and 36 080 patients with type 2 diabetes, use of real-time CGM compared with nonuse was associated with significantly lower hemoglobin A1c (difference, −0.40%) and lower rates of emergency department visits or hospitalizations for hypoglycemia (difference, −2.73%) but no significant difference for rates of emergency department visits or hospitalizations for hyperglycemia or for other reasons. MeaningAmong patients selected by physicians for real-time continuous glucose monitoring use was associated with better glycemic control and lower rates of hypoglycemia.

Journal

JAMAAmerican Medical Association

Published: Jun 8, 2021

References